IBD Training Academy

Module 3

Module 3 

Integrating the patient voice through patient-reported outcomes

Module 3 will focus on the role of patient-reported outcomes (PROs) in clinical practice to monitor outcomes important to patients, as well as the use of digital health in inflammatory bowel disease (IBD). This module will present the opportunity to share your own experiences of innovative solutions, speak to the experts about their experiences with PROs in IBD management and interrogate recent literature about the use of PROs.

Learning objectives

  • Explain the current role of PROs in practice, their value and their limitations
  • Choose the optimum PROs to evaluate different patient-important outcomes
  • Evaluate the value of digital health tools and wearables in monitoring PROs
  • Identify gaps in current PROs, in relation to the concept of comprehensive disease control, and consider how these gaps could be filled


Please complete the eLearning for this module in your own time, accessible through the window below. Don’t forget to take the quiz at the end to assess your learning.


Module host webinar|Implementing PROs in daily clinical practice 

The Module 3 'Implementing PROs in daily clinical practice' host webinar led by Dr Gareth Parkes and Dr Ana Guitérrez took place on Wednesday 13th July at 16:30-17:30 CEST. If you missed this meeting, please watch the video below. If you have any questions please do reach out to us using the contact details below. 

Expert webinar|Application of artificial intelligence in IBD

The Module 3 expert-led webinar, 'Application of artificial intelligence in IBD', with Dr Peter Bossuyt and Dr Ana Gutiérrez took place on Wednesday 27 July, 17:00-18:00 CEST. If you missed this meeting, please watch the video below. If you have any questions please do reach out to us using the contact details below.

Journal club

Journal club  

This interactive session was aimed at developing your critical appraisal skills and literature awareness, and was led by Dr Gareth Parkes on Monday 8 August, 18:00–19:00 CEST.

The two papers and pre-read questions are available to download should you wish to view them. This session was not recorded, however, the slides used during the session have been made available to download, and include a critical appraisal checklist that can be used when analysing future literature. If you have any questions please do reach out to us. 



Technology and electronic health in IBD care: supporting patient engagement

Listen to Dr Gareth Parkes and Dr Alissa Walsh as they discuss the use of digital tools in IBD management. Learn about the latest technological advances, including how PRO measures can be collected electronically and the available apps that support issues related to patient quality of life. Hear about how these advances may apply to your own clinical practice to promote shared decision-making and support HCP–patient communication. 



     Module hosts

Dr Ana Gutiérrez
Hospital General Universitario de Alicante, Alicante, Spain

Dr Gareth Parkes
The Royal London Hospital, London, UK


     Guest speakers

Dr Peter Bossuyt 
Imelda General Hospital, Bonheiden, Belgium


Dr Peter Bossuyt, Gastroenterologist at the IBD clinic of the Imelda General Hospital in Bonheiden, Belgium, is Co-director of the Imelda GI Clinical Research Centre. In 2021, Dr Bossuyt obtained his PhD at the Catholic University of Leuven. His research focusses on clinical trials, eHealth tools in IBD and defining endoscopic and imaging targets. He is an editorial board member of the JCC, board member of ECCO ClinCom, past Chair of BIRD SciCom and is currently Secretary of BIRD. He has co-authored over 100 papers in international peer-reviewed journals.

Dr Alissa Walsh
Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK


Alissa Walsh is Consultant Gastroenterologist at the John Radcliffe Hospital in Oxford, UK. She completed a clinical fellowship in IBD and an Australian National Health and Medical Research Council fellowship and has since received her DPhil in clinical medicine. Her research focusses on IBD activity indices, prevention of opportunistic infections in immunocompromised patients, faecal transplantation in UC and remote monitoring for patients with IBD. Dr Walsh is a Founder and Director of Crohn’s Colitis Cure, an Australian charity supporting IBD research.

Modules homepage

Thank you for completing Module 3. 

Go back to the homepage to view the rest of the programme.

Have a question?

Keep in touch

If you have any questions about the programme or your application, please download the FAQs or contact us.